Gerd Geerling

Preserflo MicroShunt: Efficacy and Endothelial Cell Density.

Preserflo MicroShunt effectively lowered intraocular pressure without substantial ECL after a minimum follow-up period of 17 months.

Iris Obstruction Following PRESERFLO Microshunt Implantation and Surgical Management.

Uncontrolled IOP because of iris obstruction following PMS was addressed by surgical removal of iris fibers at the lumen entrance without the need for tube repositioning.

Nd:YAG Laser Iridotomy Versus Surgical Iridectomy in Descemet Membrane Endothelial Keratoplasty: Comparison of Postoperative Outcome and Incidence of Ocular Hypertension.

Postoperative pupillary block after DMEK occurs significantly more often after preoperative Nd:YAG laser iridotomy compared with surgical intraoperative iridectomy but does not negatively affect long-term visual outcome or glaucoma incidence after DMEK.

Ten-Year Follow-Up After Descemet Membrane Endothelial Keratoplasty.

Although ECD decreases continuously in the long-term follow-up, excellent visual acuity can be preserved 10 years after DMEK and Triple-DMEK. The final outcome can be estimated 6 months after surgery.

Intraocular Pressure and Trabecular Meshwork Outflow Facility After Descemet Stripping Endothelial Keratoplasty.

IOP as measured by GAT, DCT, and Schioetz tends to increase during the first year after DSEK in eyes without previous glaucoma, whereas trabecular meshwork outflow facility as measured by Schioetz tonography improves.